Summary
This research project aims to understand the molecular mechanisms behind enhanced human airway smooth muscle (HASM) shortening in asthma, specifically focusing on type 2 (T2) inflammation and bitter taste receptors (TAS2Rs), to develop novel bronchodilators and treatment strategies.